Press Releases

10.19.2016

DILIsym Services, Inc. Utilizes Flagship Technology to Evaluate Prospective NAFLD Treatments in Collaboration with Pfizer Inc.

10.19.2016

Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection

10.17.2016

Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA® (infliximab-dyyb)

10.15.2016

Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016

10.09.2016

First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal

10.09.2016

Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC)

10.06.2016

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business From Pfizer Inc. For $1 Billion In Cash And Stock

09.28.2016

iTeos Announces Initiation of Phase 1 Clinical Trial of IDO1 inhibitor

09.28.2016

Pfizer Completes Acquisition of Medivation

09.28.2016

Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress

09.26.2016

Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation

09.23.2016

Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation